1. Home
  2. FHTX vs FLC Comparison

FHTX vs FLC Comparison

Compare FHTX & FLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Foghorn Therapeutics Inc.

FHTX

Foghorn Therapeutics Inc.

HOLD

Current Price

$1.92

Market Cap

173.4M

Sector

Health Care

ML Signal

HOLD

Logo Flaherty & Crumrine Total Return Fund Inc

FLC

Flaherty & Crumrine Total Return Fund Inc

BUY

Current Price

$15.45

Market Cap

162.4M

Sector

Finance

ML Signal

BUY

Company Overview

Basic Information
Metric
FHTX
FLC
Founded
2015
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
173.4M
162.4M
IPO Year
2020
2003

Fundamental Metrics

Financial Performance
Metric
FHTX
FLC
Price
$1.92
$15.45
Analyst Decision
Buy
Analyst Count
10
0
Target Price
★ $6.00
N/A
AVG Volume (30 Days)
★ 1.0M
42.6K
Earning Date
11-04-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
★ 25.32
N/A
EPS
N/A
★ N/A
Revenue
★ $30,909,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$15.98
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 36.75
N/A
52 Week Low
$1.79
$15.33
52 Week High
$7.61
$18.09

Technical Indicators

Market Signals
Indicator
FHTX
FLC
Relative Strength Index (RSI) 15.14 28.56
Support Level N/A N/A
Resistance Level $5.35 $17.00
Average True Range (ATR) 0.30 0.17
MACD -0.16 -0.02
Stochastic Oscillator 5.53 14.33

Price Performance

Historical Comparison
FHTX
FLC

About FHTX Foghorn Therapeutics Inc.

Foghorn Therapeutics Inc is a clinical stage, precision therapeutics biotechnology company focused on pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression through selectively targeting the chromatin regulatory system. Its proprietary platform is designed to provide an integrated, mechanistic understanding of interactions within the chromatin regulatory system, supporting the identification and validation of potential therapeutic targets. The company's flagship program is FHD-909.

About FLC Flaherty & Crumrine Total Return Fund Inc

Flaherty & Crumrine Total Return Fund Inc is a diversified, closed-end investment management company. Its investment objective is to provide its common shareholders with a high current income. The fund's secondary investment objective is capital appreciation.

Share on Social Networks: